Hristina Ivanova
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Allosteric cross-talk between the hydrophobic cleft and the BH4 domain of Bcl-2 in control of inositol 1,4,5-trisphosphate receptor activity.
Journal: Exploration of targeted anti-tumor therapy
Published: November 02, 2021
Tracing the evolutionary history of Ca2+-signaling modulation by human Bcl-2: Insights from the Capsaspora owczarzaki IP3 receptor ortholog.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: April 21, 2021
Bcl-xL acts as an inhibitor of IP3R channels, thereby antagonizing Ca2+-driven apoptosis.
Journal: Cell death and differentiation
Published: February 25, 2021
Bcl-2-Protein Family as Modulators of IP3 Receptors and Other Organellar Ca2+ Channels.
Journal: Cold Spring Harbor perspectives in biology
Published: September 11, 2019
Bcl-2 and IP3 compete for the ligand-binding domain of IP3Rs modulating Ca2+ signaling output.
Journal: Cellular and molecular life sciences : CMLS
Published: December 21, 2018
Pathophysiological consequences of isoform-specific IP3 receptor mutations.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: May 06, 2018
Modulation of Ca2+ Signaling by Anti-apoptotic B-Cell Lymphoma 2 Proteins at the Endoplasmic Reticulum-Mitochondrial Interface.
Journal: Frontiers in oncology
Published: January 20, 2017
A double point mutation at residues Ile14 and Val15 of Bcl-2 uncovers a role for the BH4 domain in both protein stability and function.
Journal: The FEBS journal
Published: December 19, 2016
Endoplasmic Reticulum-Mitochondrial Ca2+ Fluxes Underlying Cancer Cell Survival.
Journal: Frontiers in oncology
Published: December 12, 2016
The BH4 domain of Bcl-2 orthologues from different classes of vertebrates can act as an evolutionary conserved inhibitor of IP3 receptor channels.
Journal: Cell calcium
Published: November 28, 2016
The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca2+ signaling.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: September 23, 2016
The trans-membrane domain of Bcl-2α, but not its hydrophobic cleft, is a critical determinant for efficient IP3 receptor inhibition.
Journal: Oncotarget
Published: March 03, 2016
Last Updated: 09/26/2026